Thus, it is likely that a cross‐neutralizing Ab‐inducing vaccine regimen will also need to integrate components that elicit classical [15] or non‐classical CD8+ T cells [13] to prevent or clear HIV infection. Here, CD8A is linked to HIV infectious disease.